The aim of the 8th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with this theme in having over three-quarters of the presentations focused on case studies. This will be complemented by technology progress in high concentration, NMR, SPR and X-ray screening. This conference is suitable for scientists including chemists, biophysicists, structural biologists, etc., with either existing experience of fragments or wanting to learn about this exciting approach to drug discovery. This international meeting attracts delegates from the UK, several mainland European counties, as well as from the USA, Japan, China and South Korea.

Read on: rsc.org/events/detail/

The 6th International Conference on Drug discovery and drug development ”which is scheduled to commence on December 07-09, 2023 in Madrid, Spain. Drug Development Conference 2023 will serve as a global forum for debating, exchanging, and exploring new fields of research and development as well as for learning about emerging technologies and algorithms in Drug development. This year's Drug Development Conference   is expected to be three days of interactive, stimulating discussions with 10+ keynote lectures, 50+ plenary lectures, 10+ Young Investigator Forum lectures, and 20+ poster sessions. At this three -day event, give presentations, disseminate information, network with current and potential scientists, make a splash with new drug breakthroughs, and boost Drug Development reputation. There are several eminent speakers at this conference who are specialists in pharmacovigilance. They are disseminating the most recent methods, innovations, and discoveries in this crucial area. A platform to promote your ideology and ensure its value Communicate and communicate with colleagues and superiors Collaboration, Career development, etc. In addition, it offers the greatest multidisciplinary forum for pharmacists, medical professionals, researchers, practitioners, and young achievers to attend the event and discuss workable problems and answers related to Pharmacists should be aware of the latest advances, trends, and concerns in the field.

Read on alliedacademies.com

After the grand success of our first series “Global conference on Pharmaceuticals and Clinical Research”, We cordially invite you all to attend the "2nd Global Conference on Pharmaceuticals and Clinical Research" on November 23-24, 2023 in Dubai, UAE with the theme of Futuristic Advancements in Pharmaceuticals and Clinical Research

The conference provides an opportunity to network with key opinion leaders and service providers from around the world. Practicing physicians with clinical experience in a variety of treatment areas, as well as members of patient organizations, will be among the attendees. Pharmaceutical and biotech enterprises, med-tech and medical equipment companies, consulting firms, clinical research organizations, and data management corporations will all demonstrate and exhibit their wares. It will be an interdisciplinary forum for keynote talks, oral or poster presentations, workshops/symposia, and networking with scholars from all over the world to make professional network, generate new possibilities, and collaborate.

Read on scientexconference.com

The NextGen Omics 2023 Conference brings together a panel of leaders and scientists, sharing new case studies, innovative data and industry outlook. NextGen Omics 2023 features 4 outstanding programmes, bringing together Europe’s most successful omics research experts under one roof. The series provides an excellent networking platform which consists of key discussion topics in: Next Generation Sequencing & Clinical Diagnostics, Single Cell & Spatial Analysis, Synthetic Biology in Discovery & Therapeutics and Digital PCR & Liquid Biopsies. Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.

Read on oxfordglobal.co.uk

It’s an immense pleasure to invite all participants from around the world to the 4th International Conference on Drug Discovery Chemistry will be held in Dubai, UAE scheduled on October 23-25, 2023. Drug discovery 2023 focus is on “Exploring the advancements of Future Drug Discovery Research” to enhance and expand the knowledge in drug discovery research. Convocation on drug discovery will provide the perfect platform to all the Professors, practitioners, researchers, and delegate people. At this conference, we arranged an immersive program that will show you the real worth of scientific conferences and it will be game-changing for your research ideas. The conference would be a major role in the research development field. Followed by the successful conferences, drug discovery 2023 will bring together experts in clinical trials, pharmaceutical research, drug research-related industry people, research-supporting association, and healthcare people. The conference will be an extraordinary interview platform, where both young and experienced senior research people can expect long-term collaboration. It will also prove an open door to university people and young researchers. This conference will be a great place to gather for upcoming drug discovery research. The advanced drug discovery systems, AI-integrated drug discovery processes, drug design, and Proteomics in drug Discovery would be the major role of our conference. We are sure this will be the platform for gathering and disseminating the latest knowledge on recent advances and research in research from the diverse research fields covered at the conference. A platform for participants to share experiences and insights through a variety of sessions, poster presentations, seminars, and presentations. Join the drug discovery conference to meet the leading experts in drug discovery and drug design research across the country, hear them share their experiences and insights on the most extreme drug discovery needs, and interact with medical researchers and leaders in the field of research that encompasses vast networks. Drug discovery 2023 looks forward to meeting you in Dubai, worlds one of the most beautiful cities. Make the 4th annual conference on drug discovery 2023 an unforgettable occasion.
Read on drugdiscovery.alliedacademies.com

The RESOLUTE and REsolution consortia of the Innovative Medicines Initiative of the European Union have been empowering over the last years the scientific community with novel research tools and datasets for transporters of the Solute Carrier (SLC) supergroup. In 2023, both projects are coming to an end, and we would like to finish with a big celebratory and future-looking conference: “Unlocking Transporters for Drug Discovery”. The event will be held from 27th to 29th of September 2023 at the historical Palais Niederösterreich in the city center of Vienna (Austria) and it will be open to the broader scientific community. Research Empowerment on Solute Carriers. Top international scientists interested in metabolism and its regulation, drug discovery, the function and structure of membrane proteins will be speaking. For the first time, we will present to the broad scientific community the results and lessons learned by the RESOLUTE and REsolution consortia over the last five years. Please apply as early as possible, because this conference has a limited number of participants.

Read on re-solute.eu

The  Conference is delighted to invite you to attend the 11th World Congress on Pharmaceutical Research & Drug Discovery, one of its remarkable Pharmaceutical conferences, to be held during September 21-22, 2023 Paris, France, with the theme "Exploring the recent trends and advances in the field of Drug Discovery research and innovations in the pharma" emphasizing on recent areas of more optimized research techniques like rational and computer aided drug designing for the Discovery, Designing and Development of new drugs than by traditional hit and trial method. This Drug discovery 2023 Conference includes a wide range of Keynote presentations, Oral talks, and Poster presentations. The DRUG DISCOVERY 2023 anticipates participants, renowned speakers and eminent delegates across the globe to be attending the conference to share their valuable presentation and galvanize the scientific community. Scientific people from all over the globe focused on learning about emerging technologies about Drug Discovery and Advanced Drug Design Technology in the latest application. This is a best globalized opportunity to reach the largest assemblage of participants from the scientific community and research. 
Read on drug.pharmaceuticalconferences.com

iPharma Expo 2023, USA is a leading business, networking pharmaceutical event with exhibitors and visitors from major international pharma companies. After a series of many successful pharma and medical conferences and expos for the past many years, we are happy to announce the International Pharmaceutical Business Expo, iPharma Expo 2023 at San Francisco, USA during September 21- 22, 2023.The expo will showcase the latest trends and technologies in pharmaceuticals, drugs, and formulations. The expo is expected to witness approx. 150 exhibitors and 1500- 2000 visitors footfall from pharma industry & management. Direct access to highly targeted senior pharma executives, buyers, procurement managers, contract manufacturers, hospital administration, and many more Meetings with manager and business development managers who are looking for new supplies, building strategic partnerships, or entering into new ventures. iPharma Expo 2023 will provide an opportunity for the participating companies to display their products & services to the gamut of visitors, globally from the pharma and healthcare industries. The 2-day expo will bring together eminent personalities from various sectors of pharma, non-pharma, and healthcare industries. iPharma Expo 2023 is one stop juncture for all those who are planning to expand their business through various channels of franchise and distribution; as well as wholesalers and hospital purchase personnel who seek to buy bulk products on concessional rates.

Read on ipharmaexpo.com

Join World BI for its 20th edition of the flagship Drug Discovery Innovation & Outsourcing programme, taking place in beautiful Barcelona at the lovely Hotel SB Glow on September 12th- 13th 2023. This is a unique opportunity for you to connect with thought leaders from the pharma, healthcare, biotech, and life sciences industries while learning about the latest developments and newest trends in the drug discovery sector. This conference provides you with industry recommendations, case studies, and the actionable insights you need, to transform your own projects and strategically bring them to the next level through scientific discovery, collaborative research, biotech collaboration, and pharma partnerships. Join us to learn from the best in the drug development industry, including clinicians, scientists, entrepreneurs, biomedical engineers, patient advocates, and top technology providers across the globe. And if that’s not enough, the conference will be held at the Hotel SB Glow, Barcelona, where you will be just a walk away from the Museum of Design, Agbar Tower, and the beach.

Read on worldbigroup.com

The Pharma Data & Digital Medicine 2023 Conference brings together a panel of leaders and scientists, sharing new case studies, innovative data and industry outlook. An intensive 2-day meeting that delves into the latest in advancements in FAIR data, data analytics, AI and machine learning technologies in pharma, as well as latest advancements in the adoption of innovative & digital health technologies, high-performance medicine and digital biomarkers. Pharma Data & Digital Medicine 2023 to be held in London, United Kingdom between 11 September 2023 and 12 September 2023. It is organized by Oxford Global Conferences. It covers specific areas of Health and Medicine such as Pharmacology and Drug Development. Visit the website of the conference for more detailed information or contact the organizer for specific questions.

Objectives:

• Pharma Tec
• Data analytics in drug discovery
• Success in FAIR data implementation
• RWE management
• AI/ML technologies
• Multi-omic data integration and management
• Data storage & infrastructure 

Read on oxfordglobal.co.uk

The 2023 Gordon Research Seminar on Tuberculosis Drug Discovery and Development (GRS) will be held in Castelldefels, B Spain. The 2023 Gordon Research Seminar on Tuberculosis Drug Discovery and Development (GRS) will be held in Castelldefels, B Spain. The Tuberculosis Drug Discovery and Development GRS provides a unique forum for young doctoral and post-doctoral researchers to present their work, discuss new methods, cutting edge ideas, and pre-published data, as well as to build collaborative relationships with their peers. Experienced mentors and trainee moderators will facilitate active participation in scientific discussion to allow all attendees to be engaged participants rather than spectators. Applications for this meeting must be submitted by June 24, 2023. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the conference chair if more seats become available due to cancellations. Gordon Research Seminars are 2-day meetings which take place on the Saturday and Sunday just prior to the start of the associated GRC. The GRS opens with a 1-hour introductory session on Saturday afternoon, followed by a poster session, dinner and a 2-hour session in the evening. Sunday morning begins with breakfast and is followed by another 2-hour session, a second poster session, and lunch. A final 1-hour session takes place just after lunch, and the associated GRC begins later that evening.

Read on: grc.org/tuberculosis-drug-discovery

The 2023 Gordon Research Seminar on Preclinical Form and Formulation for Drug Discovery (GRS) will be held in West Dover, VT. Apply today to reserve your spot. The Preclinical Form and Formulation for Drug Discovery GRS provides a unique forum for young doctoral and post-doctoral researchers to present their work, discuss new methods, cutting edge ideas, and pre-published data, as well as to build collaborative relationships with their peers. Experienced mentors and trainee moderators will facilitate active participation in scientific discussion to allow all attendees to be engaged participants rather than spectators. The focus of this GRS is innovative drug development techniques for small, large and cell-based drug molecules. Topics of interest include, but are not limited to, analytical characterization, drug delivery challenges, and drug product formulation and processing. Additionally, experts in academia and industry will share their experience and provide a general perspective on the future of pharmaceutical research.

Read on: grc.org/preclinical-form

 MEDCHEMMEET2023 Conference provides a platform of international standards where you can discuss and share persuasive key advances in Medicinal Chemistry, Drug Discovery & Drug Delivery. In addition to Presentations, Workshops, and Discussions, the conference also offers a unique venue for renewing professional relationships, networking and for remaining up-to-date variations in our challenging and expanding discipline. Join conference on Medicinal Chemistry, Drug Discovery & Drug Delivery MEDCHEMMEET2023 which be held in Paris, France during JUNE 08-10, 2023.

Read on albedomeetings.com

The Discovery Europe 2023 Conference brings together leading experts in the fields of Organoid Discovery, Phenotypic Screening, Targeted Protein Degradation, AI Computational Drug Design and Lead Optimization. Join and network with over 400 industry leaders at the renowned Drug Discovery Summit in Berlin, where we will address the latest advancements in target identification, validation and HIT optimization. Exploring the latest advancements in phenotypic and target-based discovery, chemical biology as well as drug design at our two-day summit. The event will bring together leading experts in the fields of Organoid Discovery, Phenotypic Screening, Targeted Protein Degradation, AI Computational Drug Design and Lead Optimization. The 2023 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook. Below were some of the key speakers from our Discovery Europe 2022 event. Malcolm Weir, Executive Officer, Vice President at Sosei Heptares Ulrich Betz, Vice President Innovation, Head of Department Innovation Incubator at Merck Matthias Frech, Director, Molecular Interactions & Biophysics at Merck Clara Christ, Head of Computational Molecular Design at Bayer Olivier Nosjean, Head of Open Innovation and Scientific Affairs, R&D at Servier Nadeem Sarwar, Global Head, Genomic Strategies & Global Head, Digital Therapeutics (DTx) Strategies at Eisai.
Read on oxfordglobal.co.uk

Join World BI for its 19th edition of the flagship Drug Discovery Innovation & Outsourcing programme, taking place in sunny San Francisco at the beautiful Hyatt Regency San Francisco on June 6th- 7th. This is a unique opportunity for you to connect with thought leaders from the pharma, healthcare, biotech and life sciences industries while learning about the latest developments and newest trends in the drug discovery sector. This conference provides you with industry recommendations, case studies, and the actionable insights you need, to transform your own projects and strategically bring it to the next level through scientific discovery, collaborative research, biotech collaboration and pharma partnerships. Join us to learn from the best in the drug development industry, including clinicians, scientists, biomedical engineers, patient advocates, and top technology providers across the globe. And if that’s not enough, the conference will be held at the Hyatt Regency San Francisco Embarcadero Waterfront Hotel, where you'll get to explore the bustling Embarcadero, Union Square, and dozens of other destinations just minutes from the conference venue. Enjoy the ferry, walking tours, Segway tours, and the ease of getting to and from Oracle Park, Alcatraz Island, the Exploratorium, and much more.

Read on worldbigroup.com

With the recent approvals of ImmunoGen's ELAHERE, Astrazeneca and Daiichi Sankyo's DESTINY-Breast04, supporting Enhertu's use in HER2-low breast cancer as a new therapeutically targetable category, the ADC space has continued to make major waves throughout 2022, a joy to see for oncology patients around the world.

With high hopes set on Byondis for the next approval, you simply can't miss out on this highly anticipated event. Exploring all aspects of ADC development from discovery to late-stage manufacturing, this is your one-stop shop for antibody-drug conjugate content.

No ADC stone is left unturned as we unite all leading players in the field under one roof. Wherever your interest and expertise lies, we have it covered at the industry's leading conference to help forward-thinking researchers from the pharmaceutical, biotech, and academic community advance the development of antibody-drug conjugates.

Read on worldadc-europe.com

N-Nitrosamine impurity findings in marketed formulations of rifampin have disrupted drug development. As a strong cytochrome P450 3A4 (CYP3A4) inducer, rifampin was regularly co-administered with investigational products during pharmacokinetic drug-drug interaction studies. However, due to recent impurity issues, its application in these studies has been suspended in both the US and EU. This webinar will examine the root cause of rifampin impurity and describe the industry and regulatory response to this issue. In addition, the featured speakers will address alternative approaches and CYP3A inducers to encourage the continuation of drug-drug interaction studies and drug development.

N-Nitrosamines are a class of chemicals recognized as a “cohort of concern” due to their mutagenic and carcinogenic potential. Typically, levels above an acceptable intake limit may lead to a probable or possible risk of cancer in humans. Rifampin capsules were found to contain 1-methyl-4-nitrosopiperazine (MNP) above the acceptable intake limit of 0.16 ppm. However, it’s important to note that nitrosamines are not limited to drug products, and low levels can be found in drinking water, processed meats and tobacco exposure. Therefore, in theory, a diet low in nitrosamines could offset any potential exposure during rifampin drug-drug interaction studies.

Read on xtalks.com

The theme of Drug Development 2022 is “Innovation and Advancement in the Field of Drug Discovery and Drug Development”. Drug Development 2022, like previous congresses, encourages chemical scientists to collaborate in order to improve the quality of life around the world. Our outstanding technical program is the result of collaborations between scientists from different countries. Such collaborations could only lead to advancements in technological development and a higher quality of life for everyone.

Read on drugdevelopment.alliedacademies.com

The synthesis of long helical oligoamide foldamers composed of more than 20 aromatic monomers of 8-amino-2-quinoline carboxylic acid can now be routinely achieved by using an in lab-developed solid-phase foldamer synthesis (SPFS) methodology that relies on acid chloride activation. aThe automation of the SPFS conditions is revolutionizing the production of high molecular weight aromatic oligoamides with very good yield and purity and faster production compared to the manual approach. That constitutes a critical milestone in the field of aromatic foldamer chemistry with many concrete applications such as the modulation of protein-protein interactions in competitive research programs.

Read on xtalks.com

As the radiopharmaceutical research and development landscape continues to advance, so do the complexities and challenges associated with clinical trials. Conducting radiopharmaceutical trials presents a unique set of obstacles, such as the challenge of capturing unique radiation induced toxicities in the context of enrolled patients’ overall radiation exposure. This requires an understanding of enrolled patients’ cumulative radiation exposure from previous radiation treatments and current studies. For clinical radiopharmaceutical studies, the broader team must understand the background of radiation dosimetry, radiation toxicity, normal organ dose constraints and how to capture these metrics within clinical trial data management. In this webinar, Medpace medical, operational, regulatory and core lab experts will explore considerations for radiation toxicity and analyze previous radiopharmaceutical case studies and draw on their 30+ years of integrated, global experience to examine strategies to successfully operationalize complex radiopharmaceutical trials and increase the probability of clinical and regulatory success.

Read on xtalks.com

Association of Pharmaceutical Research (APR) organizes the “Pharma Summit 2022: Drug Discovery & Community Trial” on 27th & 28th August 2022. This conference aims to bring together leading academic scientists, researchers and scholars to exchange and share their works and research results on all aspects of Pharmacology, Pharmaceutical Biotechnology, Pharmacogenomics, Drug Delivery, Bio-drugs, Pharmacovigilance and Drug Safety, Pharmaceutical Microbiology, Pharmaceutical Research and Development, Pharmaceutical Analysis and Quality curatives, Bio-therapeutics, Radiopharmaceuticals, Vaccine Design, Formulation Technologies, Clinical Pharmacy, Industrial Pharmacy, Pharmaceutical Chemistry and Pharmaceutics.

Read on assopharm.com

Several high-profile partnerships between pharma and AI companies have materialized recently, but with commercial validation of approaches taking place, improving technologies will expedite this process. The inaugural AI Driven Drug Discovery Summit will highlight key approaches to implementing novel AI technologies to expanding datasets. With this landscape rapidly evolving, the need to determine where and how AI can most add value has never been stronger. By uniting leaders from pharma, biotech, AI-technology companies and academia, this forum allows you to create a clear strategic vision and ambition regarding the use of AI to optimize drug discovery.

Read on aidrivendrugdiscovery.com

Coming to Boston this May, the 2nd Induced Proximity-Based Drug Discovery Summit is the only industry and academic dedicated summit focused on exciting innovations and emerging case studies to establish novel strategies of identifying and optimizing drug design, physiological properties and therapeutic applications of induced proximity-based drugs.

This multidisciplinary summit will be gathering 100+ of the industry drug discovery leaders in large and small molecule disciplines to discuss how the phenomenon of induced proximity can be leveraged to precisely engineer biological outcomes such as post-translational modifications and degradation of high value targets in oncology and beyond.

Read on induced-proximity-summit.com

The pandemic triggered seismic shifts across the healthcare sector, from innovations in drug discovery, development and treatment to new approaches in patient care. As we combat new variants and slowly shift toward the pandemic-recovery phase, what are some of the lessons learned? How can we address the most pressing healthcare issues going forward? Join us for WSJ Health Forum and hear from leaders with a wide range of perspectives and expertise as we look at what’s next for the business and science of health.

Read on healthforum.wsj.com

Advanced Machine Learning and Artificial Intelligence for Innovative Drug Discovery & Development Forum will bring together global pharmaceutical industry leaders to exchange experience and share the latest discoveries using artificial intelligence (AI) and machine learning (ML) to enhance service delivery levels in health-related industries and pharmaceutical industries. During this two-day session, senior executives, experts, and business professionals will join in-depth panel discussions, view practical case studies, attend interactive sessions, and participate in development workshops.

Read on leadventgrp.com

The summit will allow you to gain knowledge on the inhibition and activation of the Wnt pathway. The Wnt & β-Catenin Targeted Drug Discovery Summit is the only meeting uniting leading pharma, pioneering biotechs, and reputed academics under a mutual and ambitious objective of accelerating your novel Wnt/β-catenin candidates into clinic and market.

Read on wnt-b-catenindrugdiscovery.com

Top-level Industry leaders from around 25+ Countries come to join DDIP and leave with an exceptional experience that they return to the conferences year after year. Delegates attending our event are asked to complete a questionnaire, which confirms their R&D budget.

Read on worldbigroup.com